
Analysis of the risks for living renal donors over the medium and long-terms. Renal assignation of an altruistic donor. Specific considerations to be taken into account during assessment. Results of paired transplantation rounds. Exchange options within the scheme (figure 14):. Foundations of the paired kt scheme in spain. Paired kidney transplantation and altruistic donors. What do we need to study to carry out an abo-incompatible ldkt?. The effectiveness of abo-incompatible ldkt. Complications and cost of desensitization. Desensitization for hla-incompatible ldkt. Considerations on choice of a live donor for children. Absolute contraindications in paediatric recipients. Living donor kt in highly sensitized paediatric recipients. Abo incompatible living donor kt and paediatric recipients. Intellectual retardation and the paediatric recipient. Complex urological anomalies and treating them in ldkt and paediatric recipient. Complex vascular anomalies in ldkt and paediatric recipients. What is the age limit for a living donor to a paediatric recipient?. Kt from an adult donor to a very young recipient (donor-recipient disassociation). Very young recipients of living donor transplantation. Advantages of living donation for paediatric recipients. Alternative drugs for maintenance immunosuppression.
Maintenance immunosuppressant treatment in ldkt recipients. Immunosuppression induction therapy in ldkt. Recommendations for the management of hla incompatibility (figure 11). Practical procedure for the study of a ldkt candidate pair. Planned study of the donor-recipient pair. Compatibility and incompatibility in living donor kt. Diabetes mellitus and metabolic syndrome. Metabolic evaluation and healthy lifestyles before and after living renal donation. Alcohol consumption and addiction to other drugs. Minor urinary alterations and their impact on donation. Living renal donors with borderline alterations: acceptance and rejection criteria. Living donor selection and acceptance criteria. Living donor psychological assessment protocol. Psychological evaluation of living renal donors. The risk of transmitting infectious diseases. Hereditary renal diseases or those with a familial component. Assessment, clinical history and specific tests for living renal donors. Time off work, economic costs, life insurance policies and applying for loans. Preliminary approach to the viability of donation. The basic information required for potential renal donors to give their consent. Information about types of renal replacement therapy. The healthcare ethics committee (hec) in living donation. Signing the informed consent (ic) document. Evaluation of non-resident living donors. Risks analysis and information for the donor. Procedure in the case of unforeseen results. Accreditation of donor identity and their relationship with the recipient. Decisions in donor selection based on sex.
Ethical aspects of living donor donation and kt.Paired transplantation and altruistic donation.detecting and reporting cases of illegality committed outside spain. Penalties for buying and selling organs.
exceptional donors: “competent” minors and “incompetent” adults.
Royal decree 1723/2012, of 28 december, which governs the activities of obtaining and clinically using human organs, and the territorial coordination of the human organs destined for transplantation, establishing quality and safety requisites. Law 30/79, of 27 october, on the harvesting and transplantation of organs, and royal decree 1723/2012, of 28 december. Regulations governing living donor kt in spain. Adapting the living donor kt scheme to new needs. The evolution of living donor kt in spain and how it compares with other countries. Changes in deceased donor profile and the waiting list. The current situation of living donor renal transplantation in spain and other countries.
Introduction, objectives and methodology.